Two medication classes reduced cardiovascular and liver events in people with type 2 diabetes GLP-1 receptor agonists (GLP-1s) and SGLT-2 inhibitors lower the risk of major cardiovascular events like heart attacks and severe liver… By Staff , in Diabetes , at June 2, 2024